SCHEMBL517463

SCHEMBL517463

COC(=O)C(C)Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
THRB P10828 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
HSD17B10 Q99714 1/20 0.60
CYP3A4 P08684 3/20 0.56
TSHR P16473 1/20 0.56
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
MAPK1 P28482 1/20 0.54
ATM Q13315 1/20 0.54
HPGD P15428 1/20 0.53
MAPT P10636 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
CA12 O43570 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2600694 1.00 ALDH1A1 (0.60) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL17761604 1.00 ALDH1A1 (0.60) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Ammonia Solution, Strong SCHEMBL9995407 0.98 ALDH1A1 (0.59) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL6576829 0.90 ALDH1A1 (0.55) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL21366441 0.86 LTA4H (0.68) NPC1RAB9AL3MBTL1
SCHEMBL27977003 0.86 LTA4H (0.68) NPC1RAB9AL3MBTL1
SCHEMBL13386048 0.86 ALDH1A1 (0.55) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL18300625 0.85 HSD17B10 (0.50) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL4591527 0.84 ACACB (0.49) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL13386099 0.83 ALDH1A1 (0.52) ALDH1A1THRBCYP2C9CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115363194-A Grape essence with white grape fragrance and application thereof 广州和泉食品有限公司 2022-11-22 CN claimed
US-20110118217-A1 Agonists for Antimicrobial Peptide Systems AKTHELIA PHARMACEUTICALS (IS) 2011-05-19 US claimed
CN-101959429-A Agonists of antimicrobial peptide systems AKTHELIA PHARMACEUTICALS 2011-01-26 CN claimed
EP-2237684-A2 AGONISTS FOR ANTIMICROBIAL PEPTIDE SYSTEMS Akthelia Pharmaceuticals (IS) 2010-10-13 EP claimed
CN-101760312-A Fruit-jasmine essence BIN ZHANG 2010-06-30 CN claimed
WO-2009087474-A2 AGONISTS FOR ANTIMICROBIAL PEPTIDE SYSTEMS AKTHELIA PHARMACEUTICALS (IS) 2009-07-16 WO claimed
US-20030036489-A1 Consumable composition comprising perfumed particles and article containing the same THE PROCTER & GAMBLE COMPANY 2003-02-20 US claimed
WO-2002090479-A1 PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO claimed
WO-2002090481-A1 COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME THE PROCTER & GAMBLE COMPANY (US) 2002-11-14 WO claimed
WO-2002015691-A1 USE FOR CONIFER SAPLING PROTECTION AGAINST INSECT ATTACK ROBIGUS AB (SE) 2002-02-28 WO claimed
US-6110449-A ANTIPERSPIRANT, PERFUMES, CYCLODEXTRIN INCLUSION COMPLEX ANDCARRIERS THE PROCTER & GAMBLE COMPANY (US) 2000-08-29 US claimed
EP-4291157-B1 FRAGRANCE DELIVERY COMPOSITIONS TAMINCO BV (BE) 2025-03-19 EP disclosed
CN-119638540-A Method for reducing alpha, beta-unsaturated ester, nitrile and amide 南开大学 2025-03-18 CN disclosed
US-12240854-B2 TRAF 6 inhibitors HELMHOLTZ ZENTRUM MUENCHEN—DEUTSCHES FORSCHUNGSZENTRUM FUERGESUNDHEIT UND UMWELT (GMBH) (DE) 2025-03-04 US disclosed
US-20240148630-A1 FRAGRANCE DELIVERY COMPOSITIONS TAMINCO BV (BE) 2024-05-09 US disclosed
CN-1212619-A Non-aqueous, slow-release pest control and air care gel compositions PENNZOIL PROD CO (US) 1999-03-31 CN disclosed
CN-1036073-C Liquid hard surface detergent compositions containing zwitierionic detergent surfactant and menoethanolamine and/or beta-aminoalkanol PROCTER & GAMBLE (US) 1997-10-08 CN disclosed
CN-1142492-A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents PFIZER (US) 1997-02-12 CN disclosed
US-4775692-A ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT TORAY INDUSTRIES, INC. (JP) 1988-10-04 US disclosed
CN-87107782-A Cause the solidified aqueous polymer systems and it is applied to the method for matrix by cationic photopolymerization 1988-06-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118217-A1 Agonists for Antimicrobial Peptide Systems VIP, GLP1R, MAVS ALDH1A1 3865/4885THRB 2144/4885CYP2C9 4646/4885
US-12240854-B2 TRAF 6 inhibitors TRAF2, TRAF6, TRAFD1 ALDH1A1 3705/4885THRB 1814/4885CYP2C9 4858/4885
US-20240148630-A1 FRAGRANCE DELIVERY COMPOSITIONS F12, P4HA1, INO80C ALDH1A1 722/4885THRB 731/4885CYP2C9 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.